Abstract
This systematic review examines current randomized clinical trials of therapeutic agents to treat coronavirus disease 2019 (COVID-19).
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Systematic Review
MeSH terms
-
Adenosine Monophosphate / analogs & derivatives
-
Adenosine Monophosphate / therapeutic use
-
Alanine / analogs & derivatives
-
Alanine / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antimalarials / therapeutic use
-
Antiviral Agents / therapeutic use
-
Azithromycin / therapeutic use
-
Betacoronavirus / isolation & purification
-
Biological Products / therapeutic use
-
COVID-19
-
COVID-19 Serotherapy
-
Chloroquine / therapeutic use*
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / mortality
-
Coronavirus Infections / therapy*
-
Coronavirus Infections / virology
-
Humans
-
Hydroxychloroquine / therapeutic use*
-
Immunization, Passive / methods
-
Non-Randomized Controlled Trials as Topic
-
Pandemics
-
Pneumonia, Viral / epidemiology*
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / therapy*
-
Pneumonia, Viral / virology
-
Protease Inhibitors / therapeutic use
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Randomized Controlled Trials as Topic
-
Respiration, Artificial / methods
-
SARS-CoV-2
-
Viral Load / drug effects
Substances
-
Anti-Bacterial Agents
-
Antibodies, Monoclonal, Humanized
-
Antimalarials
-
Antiviral Agents
-
Biological Products
-
Protease Inhibitors
-
remdesivir
-
Adenosine Monophosphate
-
Hydroxychloroquine
-
Azithromycin
-
Chloroquine
-
Protein-Tyrosine Kinases
-
tocilizumab
-
Alanine